AAAAAA

   
Results: 1-20 |
Results: 20
The evolution of A beta peptide burden in the APP23 transgenic mice: Implications for A beta deposition in Alzheimer disease
Authors: Kuo, YM Beach, TG Sue, LI Scott, S Layne, KJ Kokjohn, TA Kalback, WM Luehrs, DC Vishnivetskaya, TA Abramowski, D Sturchler-Pierrat, C Staufenbiel, M Weller, RO Roher, AE
Citation: Ym. Kuo et al., The evolution of A beta peptide burden in the APP23 transgenic mice: Implications for A beta deposition in Alzheimer disease, MOL MED, 7(9), 2001, pp. 609-618
Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine
Authors: Beach, TG Kuo, YM Schwab, C Walker, DG Roher, AE
Citation: Tg. Beach et al., Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine, NEUROSCI L, 310(1), 2001, pp. 21-24
Comparative analysis of amyloid-beta chemical structure and amyloid plaquemorphology of transgenic mouse and Alzheimer's disease brains
Authors: Kuo, YM Kokjohn, TA Beach, TG Sue, LI Brune, D Lopez, JC Kalback, WM Abramowski, D Sturchler-Pierrat, C Staufenbiel, M Roher, AE
Citation: Ym. Kuo et al., Comparative analysis of amyloid-beta chemical structure and amyloid plaquemorphology of transgenic mouse and Alzheimer's disease brains, J BIOL CHEM, 276(16), 2001, pp. 12991-12998
Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative post-translational modification of amyloid deposits
Authors: Atwood, CS Huang, XD Moir, RD Smith, MA Tanzi, RE Roher, AE Bush, AI Perry, G
Citation: Cs. Atwood et al., Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative post-translational modification of amyloid deposits, ALZHEIMER'S DISEASE, 2001, pp. 341-361
Elevated A beta and apolipoprotein E in A beta PP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease
Authors: Kuo, YM Crawford, F Mullan, M Kokjohn, TA Emmerling, MR Weller, RO Roher, AE
Citation: Ym. Kuo et al., Elevated A beta and apolipoprotein E in A beta PP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease, MOL MED, 6(5), 2000, pp. 430-439
Oligomerization and fibril assembly of the amyloid-beta protein
Authors: Roher, AE Baudry, J Chaney, MO Kuo, YM Stine, WB Emmerling, MR
Citation: Ae. Roher et al., Oligomerization and fibril assembly of the amyloid-beta protein, BBA-MOL BAS, 1502(1), 2000, pp. 31-43
Cholinergic deafferentation of the rabbit cortex: a new animal model of A beta deposition
Authors: Beach, TG Potter, PE Kuo, YM Emmerling, MR Durham, RA Webster, SD Walker, DG Sue, LI Scott, S Layne, KJ Roher, AE
Citation: Tg. Beach et al., Cholinergic deafferentation of the rabbit cortex: a new animal model of A beta deposition, NEUROSCI L, 283(1), 2000, pp. 9-12
Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice
Authors: Kane, MD Lipinski, WJ Callahan, MJ Bian, F Durham, RA Schwarz, RD Roher, AE Walker, LC
Citation: Md. Kane et al., Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice, J NEUROSC, 20(10), 2000, pp. 3606-3611
Copper catalyzed oxidation of alzheimer A beta
Authors: Atwood, CS Huang, XD Khatri, A Scarpa, RC Kim, YS Moir, RD Tanzi, RE Roher, AE Bush, AI
Citation: Cs. Atwood et al., Copper catalyzed oxidation of alzheimer A beta, CELL MOL B, 46(4), 2000, pp. 777-783
The cholinergic deficit coincides with A beta deposition at the earliest histopathologic stages of Alzheimer disease
Authors: Beach, TG Kuo, YM Spiegel, K Emmerling, MR Sue, LI Kokjohn, K Roher, AE
Citation: Tg. Beach et al., The cholinergic deficit coincides with A beta deposition at the earliest histopathologic stages of Alzheimer disease, J NE EXP NE, 59(4), 2000, pp. 308-313
SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides
Authors: Munson, GW Roher, AE Kuo, YM Gilligan, SM Reardon, CA Getz, GS LaDu, MJ
Citation: Gw. Munson et al., SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides, BIOCHEM, 39(51), 2000, pp. 16119-16124
Amyloid-beta peptides interact with plasma proteins and erythrocytes: Implications for their quantitation in plasma
Authors: Kuo, YM Kokjohn, TA Kalback, W Luehrs, D Galasko, DR Chevallier, N Koo, EH Emmerling, MR Roher, AE
Citation: Ym. Kuo et al., Amyloid-beta peptides interact with plasma proteins and erythrocytes: Implications for their quantitation in plasma, BIOC BIOP R, 268(3), 2000, pp. 750-756
Elevated A beta 42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of A beta PP metabolism
Authors: Kuo, YM Kokjohn, TA Watson, MD Woods, AS Cotter, RJ Sue, LI Kalback, WM Emmerling, MR Beach, TG Roher, AE
Citation: Ym. Kuo et al., Elevated A beta 42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of A beta PP metabolism, AM J PATH, 156(3), 2000, pp. 797-805
Amyloid and lipids in the pathology of Alzheimer disease
Authors: Roher, AE Kuo, YM Kokjohn, KM Emmerling, MR Gracon, S
Citation: Ae. Roher et al., Amyloid and lipids in the pathology of Alzheimer disease, AMYLOID, 6(2), 1999, pp. 136-145
Isolation of amyloid deposits from brain
Authors: Roher, AE Kuo, YM
Citation: Ae. Roher et Ym. Kuo, Isolation of amyloid deposits from brain, METH ENZYM, 309, 1999, pp. 58-67
Chemical modifications of deposited amyloid-beta peptides
Authors: Lowenson, JD Clarke, S Roher, AE
Citation: Jd. Lowenson et al., Chemical modifications of deposited amyloid-beta peptides, METH ENZYM, 309, 1999, pp. 89-105
High levels of circulating A beta 42 are sequestered by plasma proteins inAlzheimer's disease
Authors: Kuo, YM Emmerling, MR Lampert, HC Hempelman, SR Kokjohn, TA Woods, AS Cotter, RJ Roher, AE
Citation: Ym. Kuo et al., High levels of circulating A beta 42 are sequestered by plasma proteins inAlzheimer's disease, BIOC BIOP R, 257(3), 1999, pp. 787-791
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease
Authors: Lue, LF Kuo, YM Roher, AE Brachova, L Shen, Y Sue, L Beach, T Kurth, JH Rydel, RE Rogers, J
Citation: Lf. Lue et al., Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease, AM J PATH, 155(3), 1999, pp. 853-862
RAGE-A beta interactions in the pathophysiology of Alzheimer's disease
Authors: Yan, SD Stern, D Kane, MD Kuo, YM Lampert, HC Roher, AE
Citation: Sd. Yan et al., RAGE-A beta interactions in the pathophysiology of Alzheimer's disease, REST NEUROL, 12(2-3), 1998, pp. 167-173
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain A beta 1-42 levels
Authors: Kuo, YM Emmerling, MR Bisgaier, CL Essenburg, AD Lampert, HC Drumm, D Roher, AE
Citation: Ym. Kuo et al., Elevated low-density lipoprotein in Alzheimer's disease correlates with brain A beta 1-42 levels, BIOC BIOP R, 252(3), 1998, pp. 711-715
Risultati: 1-20 |